Give me A5 for lipoprotein hydrolysis!

Journal of Clinical Investigation

Volumn 115, Issue 10, 2005, Pages 2694-2696

  Merkel, Martin ^a   Heeren, Joerg ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A5; LIPOPROTEIN; LIPOPROTEIN LIPASE; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; PROTEOHEPARAN SULFATE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

BLOOD VESSEL WALL; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; GENE MUTATION; HUMAN; HYPERTRIGLYCERIDEMIA; LIPOLYSIS; LIPOPROTEIN METABOLISM; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR ENDOTHELIUM;

AMINO ACID SUBSTITUTION; ANIMALS; APOLIPOPROTEINS; APOLIPOPROTEINS A; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; HUMANS; HYDROLYSIS; LIPOPROTEIN LIPASE; LIPOPROTEINS; PLASMA; POINT MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN BINDING; PROTEOGLYCANS; TRIGLYCERIDES;

EID: 26444612171     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI26712     Document Type: Review

References (26)

1. Wolfrum, C., Poy, M.N., and Stoffel, M. 2005. Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis. Nat. Med. 11:418-422.
2. Pennacchio, L.A., et al. 2001. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science. 294:169-173.
3. van der Vliet, H.N., et al. 2001. Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration. J. Biol. Chem. 276:44512-44520.
4. O'Brien, P.J., et al. 2005. The novel apolipoprotein A5 is present in human derum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins. Clin. Chem. 51:351-359.
5. Marçais, C., et al. 2005. Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment. J. Clin. Invest. 115:2862-2869. doi:10.1172/JCI24471.
6. Merkel, M., Eckel, R.H., and Goldberg, I.J. 2002. Lipoprotein lipase: genetics, lipid uptake and regulation. J. Lipid Res. 43:1997-2006.
7. Brunzell, J.D., and Deeb, S. 2001. Familial lipoprotein lipase deficiency, apo CII deficiency, and hepatic lipase deficiency. In The metabolic and molecular bases of inherited disease. Volume 2. C.R. Scriver, A.L. Beaudet, D. Valle, and W.S. Sly, editors. McGraw-Hill. New York, New York, USA. 2789-2816.
8. Lee, K.W., Ayyobi, A.F., Frohlich, J.J., and Hill, J.S. 2004. APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FER(HDL) but is not a risk factor for coronary artery disease. Atherosclerosis. 176:165-172.
9. Pennacchio, L.A., et al. 2002. Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum. Mol. Genet. 11:3031-3038.
10. Talmud, P.J., et al. 2002. Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum. Mol. Genet. 11:3039-3046.
11. Evans, D., Buchwald, A., and Beil, F.U. 2003. The single nucleotide polymorphism -1131T>C in the apolipoprotein A5 (APOA5) gene is associated with elevated triglycerides in patients with hyperlipidemia. J. Mol. Med. 81:645-654.
12. Aouizerat, B.E., et al. 2003. Genetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids. J. Lipid Res. 44:1167-1173.
13. Eichenbaum-Voline, S., et al. 2004. Linkage and association between distinct variants of the APOA1/C3/A4/A5 gene cluster and familial combined hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 24:167-174.
14. Mar, R., et al. 2004. Association of the APOLIPO-PROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia. Circ. Res. 94:993-999.
15. Weinberg, R.B., et al. 2003. Structure and interfacial properties of human apolipoprotein A-V. J. Biol. Chem. 278:34438-34444.
16. Beckstead, J.A., et al. 2003. Structure-function studies of human apolipoprotein A-V: a regulator of plasma lipid homeostasis. Biochemistry. 42:9416-9423.
17. Olofsson, S.O. 2005. ApoA-V: the regulation of a regulator of plasma triglycerides. Arterioscler. Thromb. Vasc. Biol. 25:1097-1099.
18. Fruchart-Najib, J., et al. 2004. Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5. Biochem. Biophys. Res. Commun. 319:397-404.
19. Merkel, M., et al. 2005. Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan bound lipoprotein lipase. J. Biol. Chem. 280:21553-21560.
20. Schaap, F.G., et al. 2004. ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis. J. Biol. Chem. 279:27941-27947.
21. Lookene, A., Beckstead, J.A., Nilsson, S., Olivecrona, G., and Ryan, R.O. 2005. Apolipoprotein A-V-heparin interactions: implications for plasma lipoprotein metabolism. J. Biol. Chem. 280:25383-25387.
22. Olivecrona, G., and Olivecrona, T. 1995. Triglyceride lipases and atherosclerosis. Curr. Opin. Lipidol. 6:291-305.
23. Goldberg, I.J. 1996. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J. Lipid Res. 37:693-707.
24. Merkel, M., et al. 2002. Inactive lipoprotein lipase (LPL) alone increases selective cholesterol ester uptake in vivo, whereas in the presence of active LPL it also increases triglyceride hydrolysis and whole particle lipoprotein uptake. J. Biol. Chem. 277:7405-7411.
25. Havel, R.J., and Kane, J.P. 2001. Structure and metabolism of plasma lipoproteins. in The metabolic and molecular bases of inherited disease. Volume 2. C.R. Scriver, A.L. Beaudet, D. Valle, and W.S. Sly, editors. McGraw-Hill. New York, New York, USA. 2705-2716.
26. Oliva, C.P., et al. 2005. Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia. Arterioscler. Thromb. Vasc. Biol. 25:411-417.